<DOC>
	<DOCNO>NCT01595867</DOCNO>
	<brief_summary>This single-dose , randomize , double-blind , placebo-controlled , 3 way crossover study design evaluate relative abuse potential crush EMBEDAÂ® compare morphine sulfate CR tablet placebo healthy male female , non-dependent , recreational opioid user . An appropriate dose morphine sulfate CR ( i.e. , 30 mg , 60 90 mg ) select Part A study ( Dose Selection Phase ) . Each subject participate study ( approximately ) 16 week confine clinic total 12 night .</brief_summary>
	<brief_title>Abuse Potential Assessment Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Healthy male female subject 18 55 year age , inclusive . Subject recreational opioid user NOT dependent opioids base Diagnostic Statistical Manual Mental DisordersFourth EditionText Revision ( DSMIVTR ) criteria Naloxone Challenge . A recreational opioid user define use opioids nontherapeutic purpose ( i.e. , psychoactive effect ) least 10 occasion within last year least 12 week Screening Visit ( Visit 1 ) . Subjects must experience intranasal drug administration , define intranasal use least 3 occasion within last year prior Screening Visit . Diagnosis substance and/or alcohol dependence ( exclude caffeine nicotine ) , assess Investigator use DSM IVTR criterion . Has participate , currently participate , seek treatment substance alcoholrelated disorder ( exclude nicotine caffeine ) . Has condition opioid contraindicate ; e.g. , significant respiratory depression , acute severe bronchial asthma hypercarbia , suspect paralytic ileus . Allergy history hypersensitivity morphine sulfate , opioids , naltrexone hydrochloride , naloxone , and/or lactose . History current clinically significant neurological , cardiovascular , renal , hepatic , endocrine , gastrointestinal , hematologic , metabolic disease evaluate Investigator . History current pulmonary disease include asthma , chronic obstructive pulmonary disease , exerciseinduced asthma , bronchitis , obstructive sleep apnea .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>abuse liability</keyword>
	<keyword>abuse potential</keyword>
	<keyword>morphine</keyword>
	<keyword>intranasal administration</keyword>
	<keyword>snort</keyword>
	<keyword>opioid abuse</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>recreational drug use</keyword>
</DOC>